Covered recipient · General Payments record
ANNAKATHRYN KEIPER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$3,483.61
- Reported across 149 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $765.40 | 34 |
| Education | $8.45 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $243.59 | 12 |
| Almirall LLC | $98.43 | 4 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $70.28 | 3 |
| PFIZER INC. | $70.07 | 4 |
| GENZYME CORPORATION | $60.72 | 2 |
| Incyte Corporation | $49.98 | 2 |
| Amgen Inc. | $48.90 | 2 |
| E.R. Squibb & Sons, L.L.C. | $36.79 | 2 |
| Dermavant Sciences, Inc. | $29.28 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $29.11 | 1 |
| Janssen Biotech, Inc. | $19.00 | 1 |
| Galderma Laboratories, L.P. | $17.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.20 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107445902 | CMS |
| ABBVIE INC. | $27.47 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107445904 | CMS |
| ABBVIE INC. | $8.45 | 02/29/2024 | Education | Undisputed | 01/23/2026 | 1107445906 | CMS |
| ABBVIE INC. | $22.54 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107445908 | CMS |
| ABBVIE INC. | $14.62 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107445910 | CMS |
| ABBVIE INC. | $25.01 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107445912 | CMS |
| ABBVIE INC. | $23.86 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107445914 | CMS |
| ABBVIE INC. | $25.01 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107445916 | CMS |
| ABBVIE INC. | $29.63 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107445918 | CMS |
| ABBVIE INC. | $20.21 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107445920 | CMS |
| ABBVIE INC. | $24.15 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107445922 | CMS |
| ABBVIE INC. | $15.44 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107445924 | CMS |
| Almirall LLC | $32.97 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120635779 | CMS |
| Almirall LLC | $24.64 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120635752 | CMS |
| Almirall LLC | $18.82 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120635890 | CMS |
| Almirall LLC | $22.00 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120635931 | CMS |
| Amgen Inc. | $17.39 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117595525 | CMS |
| Amgen Inc. | $31.51 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117595527 | CMS |
| Dermavant Sciences, Inc. | $29.28 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127986277 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.64 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101294777 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.15 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101294799 | CMS |
| Galderma Laboratories, L.P. | $17.70 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145368317 | CMS |
| GENZYME CORPORATION | $32.66 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139941761 | CMS |
| GENZYME CORPORATION | $28.06 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139941779 | CMS |
| Incyte Corporation | $24.14 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141265727 | CMS |
| Incyte Corporation | $25.84 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141312151 | CMS |
| Janssen Biotech, Inc. | $19.00 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078636238 | CMS |
| Novartis Pharmaceuticals Corporation | $29.11 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086989824 | CMS |
| PFIZER INC. | $20.37 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130951992 | CMS |
| PFIZER INC. | $19.22 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131043823 | CMS |
| PFIZER INC. | $15.24 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131871947 | CMS |
| PFIZER INC. | $15.24 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131011903 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $26.95 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152218748 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $21.99 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152218750 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $21.34 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152218752 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.